
## **Trustees’ Annual Report for the period** 

**From Period start date 26/09/2020       To Period end date 25/09/2021** 

## **Charity name: SICKLEKAN SICKLE CELL FOUNDATION** 

**Charity registration number: 1174838** 

## **Objectives and Activities** 


**----- Start of picture text -----**<br>
SORP reference<br>Summary of the  Para 1.17 TO RELIEVE THE NEEDS OF<br>purposes of the charity  PEOPLE AFFECTED BY SICKLE<br>as set out in its  CELL DISEASE, THEIR FAMILIES<br>governing document AND CARERS FOR THE PUBLIC<br>BENEFIT BY: 1) IMPROVING<br>AWARENESS OF SICKLE CELL<br>DISEASE FOR THE GENERAL<br>PUBLIC, SERVICE AND HEALTH<br>CARE PROVIDERS; 2) ENABLING<br>PEOPLE AFFECTED BY SICKLE<br>CELL DISEASE TO RAISE<br>AWARENESS OF THEIR NEEDS IN<br>THEIR LOCAL AND WIDER<br>COMMUNITIES; 3) SUPPORTING<br>THE PROVISION OF SUITABLE<br>ADJUSTMENTS TO CATER FOR THE<br>NEEDS OF PEOPLE WITH SICKLE<br>CELL DISEASE.<br>Summary of the main  Para 1.17 and  1)TO HELP SUPPORT AND<br>1.19<br>activities in relation to  PROVIDE GUIDANCE FOR<br>those purposes for the  CHILDREN PARENTS AND<br>public benefit, in  FAMILIES AFFECTED BY SICKLE<br>particular, the activities,  CELL DISEASE<br>projects or services<br>identified in the  2)TO ENCOURAGE MORE BLOOD<br>accounts. DONORS FOR SICKLE CELL<br>PATIENTS NEEDING BLOOD<br>TRANSFUSIONS<br>3)TO PROVIDE HELP AND<br>GUIDANCE TO SCHOOLS,<br>BUSINESSES AND AUTHORITIES<br>THAT HAVE MEMBERS THAT HAVE<br>SICKLE CELL DISEASE<br>4) TO PROVIDE A PLATFORM FOR<br>SICKLE CELL PATIENTS TO HAVE A<br>VOICE<br>**----- End of picture text -----**<br>




## **5) TO PROVIDE A BETTER FUTURE FOR THE NEXT GENERATION OF SICKLE CELL PATIENTS** 


**----- Start of picture text -----**<br>
Para 1.18<br>**----- End of picture text -----**<br>


## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other 

## **Achievements and Performance** 

SORP reference Summary of the main **Sicklekan Sickle Cell foundation** Para 1.20 achievements of the **has slowly recovered from the** charity, identifying the **early end of 2020 as The Covid 19** difference the charity’s **pandemic affected the country** work has made to the **and our ability to do outreach** circumstances of its **and support with the founder of** beneficiaries and any **the charity affected heavily from** wider benefits to society **Covid 19. However during the** as a whole. **following year Of 2020-2021 we have resumed some of our main objectives** 

**Our activities have been  split between  a few virtual events via zoom, telephone and teams calls as well as online campaigning. As well as a few  face to face counselling and outreach services** 



**Even though this  year was an improvement  on the previous year which was  very challenging for us the charity has still upheld its ethos of promoting awareness of sickle cell and assisting the local and wider community of sickle cell patients the best way we can.** 

## **Additional information (optional)** 

You may choose to include further statements where relevant about: 


**----- Start of picture text -----**<br>
Achievements against  Para 1.41<br>objectives set<br>Performance of<br>fundraising activities  Para 1.41<br>against objectives set<br>Investment performance  Para 1.41<br>against objectives<br>Other<br>**----- End of picture text -----**<br>




## **Financial Review** 

Review of the charity’s Para 1.21 financial position at the end of the period Statement explaining the Para 1.22 policy for holding reserves stating why they are held Amount of reserves held Para 1.22 Reasons for holding zero Para 1.22 reserves Details of fund materially Para 1.24 in deficit Explanation of any Para 1.23 uncertainties about the charity continuing as a going concern 

## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

The charity’s principal sources of funds Para 1.47 (including any fundraising) Investment policy and objectives including any Para 1.46 social investment policy adopted A description of the Para 1.46 principal risks facing the charity Other 



## **Structure, Governance and Management** 


**----- Start of picture text -----**<br>
Description of charity’s<br>trusts:<br>Type of governing  Para 1.25 Charter<br>document<br>(trust deed, royal<br>charter)<br>How is the charity  Para 1.25 CIO<br>constituted?<br>(e.g unincorporated<br>association, CIO)<br>Trustee selection  Para 1.25 Interview process then vote then<br>methods including  selection<br>details of any<br>constitutional provisions<br>e.g. election to post or<br>name of any person or<br>body entitled to appoint<br>one or more trustees<br>**----- End of picture text -----**<br>


## **Additional information (optional)** 

You may choose to include further statements where relevant about: 


**----- Start of picture text -----**<br>
Policies and procedures<br>adopted for the induction Para 1.51<br>and training of trustees<br>The charity’s<br>organisational structure  Para 1.51<br>and any wider network<br>with which the charity<br>works<br>Relationship with any  Para 1.51<br>related parties<br>Other<br>**----- End of picture text -----**<br>


## **Reference and Administrative details** 


**----- Start of picture text -----**<br>
Charity name Sicklekan Sickle Cell Foundation<br>Other name the charity<br>uses<br>Registered charity  1174838<br>number<br>**----- End of picture text -----**<br>




||Charity’s principal<br>address|Flat 3 Hay House Border crescent London SE26 6DD||
|---|---|---|---|
|||||





## **Names of the charity trustees who manage the charity** 


**----- Start of picture text -----**<br>
Name of person (or body)<br>Dates acted if not for<br>Trustee name Office (if any) entitled to appoint trustee<br>whole year<br>(if any)<br>1 Kehinde Salami<br>2 Lanre Owolabi<br>Iman Davidson<br>3<br>Fuller<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20<br>**----- End of picture text -----**<br>


Corporate trustees – names of the directors at the date the report was approved **Director name** 

Name of trustees holding title to property belonging to the charity 


**----- Start of picture text -----**<br>
Trustee name Dates acted if not for<br>whole year<br>**----- End of picture text -----**<br>




**Funds held as custodian trustees on behalf of others** 

Description of the assets held in this capacity 

Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

**Type of Name Address adviser** 

**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above. Signed on behalf of the charity’s trustees Signature(s)** Kehinde Salami **Full name(s)** Kehinde Salami 

**Position (eg** Founder, Director **Secretary, Chair, etc)** 

**Date** 27/07/2021 




**Sicklekan Sickle Cell  Foundation** 

**No (if any) 1174838** 

## **Receipts and payments accounts** 

Period start date 9/25/2021 **To** 9/26/2020 

**For the period from** 

## **Section A Receipts and payments** 

**Unrestricted Restricted Endowment Income Total funds funds funds funds** 

**to the nearest £** 

**to the nearest £** 

**to the nearest £ to the nearest £** 

## **A1 Receipts** 


**----- Start of picture text -----**<br>
                    4,000                            -                              -                        4,000<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>                    4,000                            -                              -                        4,000<br>Sub total (Gross income for AR)<br>A2 Asset and investment sales,<br>(see table).<br>                            -                              -                              -                            -<br>                            -                              -                              -                            -<br>Sub total                              -                              -                              -                            -<br>Total receipts                  4,000                          -                          -                      4,000<br>A3 Payments<br>WEBSITE                     1,100                            -                              -                        1,100<br>POSTAGE AND PACKAGING                        400                            -                              -                           400<br>GAS AND ELECTRIC                        400                            -                              -                           400<br>TRAVEL                        150                            -                              -                           150<br>TEESHIRTS AND FLYERS                        650                            -                              -                           650<br>ADVERTISING                        300                            -                              -                           300<br>OTHER                        200                            -                              -                           200<br>                            -                            -                              -                              -<br>                            -                            -                              -                              -<br>Sub total [                    3,200 ]                           -                              -                        3,200<br>A4 Asset and investment<br>purchases, (see table)<br>                            -                              -                              -                            -<br>                            -                              -                              -                            -<br>Sub total [                            - ]                             -                              -                            -<br>Total payments                  3,200                          -                          -                      3,200<br>Net of receipts/(payments)                     800                        -                          -                        800<br>A5 Transfers between funds                         -                        -                          -                              -<br>A6 Cash funds last year end                          -                        -                          -                          -<br>Cash funds this year end                     800                        -                          -                        800<br>**----- End of picture text -----**<br>




## **Section B Statement of assets and liabilities at the end of the period** 

||||**Unrestricted**||**Restricted**|
|---|---|---|---|---|---|
|**Categories**|**Details**||**funds**||**funds**|
|**B1 Cash funds**||**_Total cash funds_**|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**|<br> <br> <br>|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**|
||(agree|balances with receipts and payments<br>account(s))|Agreement Error|OK||
||||**Unrestricted**||**Restricted**|
||||**funds**||**funds**|
|**B2 Other monetary assets**|**Details**||**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|<br> <br> <br> <br> <br>|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|
|**B3 Investment assets**|**Details**||**Fund to which**<br>**asset belongs**|**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||
|**B4 Assets retained for the**|**Details**||**Fund to which**<br>**asset belongs**|**Cost (optional)**<br>**-**||
|**charity’s own use**||||<br> <br> <br> <br> <br> <br> <br>|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|
|**B5 Liabilities**|**Details**||**Fund to which**<br>**liability relates**|<br> <br> <br> <br>|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Amount due**<br>**(optional)**|
|Signed by one or two trustees on<br>behalf of all the trustees||Signature|Print|Name||
||Kehinde Salami||Kehinde Salami|||






**----- Start of picture text -----**<br>
CC16a<br>**----- End of picture text -----**<br>


## **Last year** 

**to the nearest £** 

**1,000 - - - - - - - 1,000** 

**1,000** 

**-** 

**1,000 - - 1,000** 



## **Endowment funds** 

**to nearest £ - - - -** 

OK 

**Endowment funds to nearest £ - - - - - - Current value (optional) - - - - - Current value (optional) - - - - - - - - - When due (optional)** 


**----- Start of picture text -----**<br>
Date of<br>approval<br>2707/2022<br>**----- End of picture text -----**<br>


